In CML, targeting CRM1 significantly induced cell apoptosis and reversed drug resistance (20, 22, 23), suggesting that effective regulation of protein localization in CML cells may have great significance for prognosis. The gene discussed is XPO1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.